Raltegravir: First in class HIV integrase inhibitor

Zelalem Temesgen, Dawd S. Siraj

Research output: Contribution to journalReview articlepeer-review

50 Scopus citations


Dive into the research topics of 'Raltegravir: First in class HIV integrase inhibitor'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds

Social Sciences

Engineering & Materials Science